Skip to main content

Table 2 Mesenchymal stem cell characteristics

From: Efficacy of mesenchymal stem cell therapy in rodent models of radiation-induced xerostomia and oral mucositis: a systematic review

Author/Years

Sources

Control group

Manipulation

Dose

Volume

Delivery route

Radiation-induced xerostomia

An et al. 2015 [39]

hAdMSCs

PBS

Hypoxia

1 × 105

500μl

Intravenous injection

Kim et al. 2019 [40]

hAdMSCs

PBS

Non

1 × 105

Unkown

Intraglandular injection

Choi et al. 2018 [15]

hAdMSCs

PBS

Matrix

1 × 105

20 μl

Intraglandular injection

Shin et al. 2018 [41]

hAdMSCs

PBS

Hypoxia

2 × 105

10 μl

Intraglandular injection

Lim et al. 2013 [30]

BM-MSCs

PBS

Non

1 × 105

15 μl

Intraglandular injection

Saylam et al. 2017 [43]

AdMSCs

PBS

Non

2 × 106

Unkown

Intraperitoneal injection

Lim et al. 2013 [42]

AdMSCs

PBS

Non

1 × 106

Unkown

Intravenous injection

Mulyani et al. 2019 [44]

BM-MSCs

PBS

Hypoxia

Unkown

Unkown

Unkown

Radiation-induced oral mucositis

Maria et al. 2016 [38]

AdMSCs

PBS

Non

2.5 × 106

500 μl

Intraperitoneal injection

Elsaadany et al. 2017 [13]

BM-MSCs

PBS

Non

1 × 107

0.2 ml

Intravenous injection

Schmidt et al. 2014 [14]

BM-MSCs

PBS

Non

6 × 106

Unkown

Intravenous injection

Shen et al. 2018 [35]

hBM-MSCs

PBS

Genetic

Unknown

Unknown

Intravenous injection

  1. AdMSCs Adipose tissue-derived mesenchymal stem cells; BM-MSCs Bone marrow-derived mesenchymal stem cells; PBS Phosphate buffered saline